Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CRSA

Crescent Acquisition (CRSA) Stock Price, News & Analysis

About Crescent Acquisition Stock (NASDAQ:CRSA)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$6.26
$10.02
52-Week Range
N/A
Volume
319,033 shs
Average Volume
631,338 shs
Market Capitalization
$116.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CRSA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Crescent Acquisition and its competitors with MarketBeat's FREE daily newsletter.

CRSA Stock News Headlines

GlycoMimetics Agrees to Acquire Crescent Biopharma
AI Meltdown Imminent: Dump These Stocks Now!
If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.
See More Headlines

CRSA Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Crescent Acquisition investors own include C3.ai (AI), Advanced Micro Devices (AMD), atai Life Sciences (ATAI), Conduent (CNDT), CrowdStrike (CRWD) and Ford Motor (F).

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
Amusement & Recreation Services
Sub-Industry
N/A
Current Symbol
NASDAQ:CRSA
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$2.49 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
62.68%
Return on Assets
1.23%

Debt

Debt-to-Equity Ratio
0.39
Current Ratio
0.11
Quick Ratio
0.11

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.67 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
31,238,000
Free Float
N/A
Market Cap
$116.52 million
Optionable
Not Optionable
Beta
N/A
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:CRSA) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners